Physician profile
Suma Dronavalli
NPI 1679525679
$4,797.59
in general payments reported to CMS, 2019-2025
42 companies · $442 in 2025
The $442 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,234 · 2020: $102 · 2021: $640 · 2022: $830 · 2023: $647 · 2024: $902 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,946 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,946.21 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $523.14 | 2019-2025 | Evenity |
| Abbott Laboratories | $492.52 | 2021-2025 | Freestyle Libre 3 |
| Corcept Therapeutics | $429.19 | 2019-2023 | Korlym |
| Novo Nordisk INC | $355.66 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $296.09 | 2019-2024 | Botox |
| Lilly USA, LLC | $250.87 | 2019-2025 | Jardiance, Mounjaro |
| Beta Bionics, INC. | $243.24 | 2023-2024 | Ilet Bionic Pancreas |
| Mannkind Corporation | $194.61 | 2019-2025 | Afrezza |
| Inspire Medical Systems, INC. | $177.19 | 2024 | Inspire |
| Ucb, INC. | $169.12 | 2023-2025 | Zilbrysq, Rystiggo |
| Tandem Diabetes Care, INC. | $158.22 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Radius Health, INC. | $122.16 | 2024 | Tymlos |
| Pfizer INC. | $117.82 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $114.67 | 2019-2024 | Austedo Xr, Austedo |
| Sanofi-Aventis U.S. LLC | $104.93 | 2019 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suma Dronavalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.